The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.
Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
93 | 79 | 67 | 41 |
Growth
|
13 | 33 | 77 | 83 |
Safety
|
34 | 59 | 67 | 39 |
Sentiment
|
3 | 24 | 18 | 39 |
|
11 | 36 | 74 | 41 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Analyst Opinions
|
34 | 63 | 47 | 100 |
Opinions Change
|
31 | 46 | 50 | 39 |
Pro Holdings
|
n/a | 12 | 12 | 13 |
Market Pulse
|
20 | 47 | 57 | 50 |
Sentiment
|
3 | 24 | 18 | 39 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
93 | 79 | 67 | 41 |
Growth
|
13 | 33 | 77 | 83 |
|
34 | 59 | 67 | 39 |
Combined
|
31 | 54 | 93 | 50 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Price vs. Sales (P/S)
|
86 | 73 | 28 | 29 |
Price vs. Earnings (P/E)
|
86 | 84 | 83 | 43 |
Price vs. Book (P/B)
|
87 | 88 | 86 | 68 |
Dividend Yield
|
1 | 1 | 1 | 1 |
Value
|
93 | 79 | 67 | 41 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue Growth
|
7 | 47 | 49 | 69 |
Profit Growth
|
24 | 92 | 88 | 65 |
Capital Growth
|
65 | 21 | 100 | 95 |
Stock Returns
|
1 | 9 | 33 | 33 |
Growth
|
13 | 33 | 77 | 83 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Leverage
|
21 | 38 | 40 | 48 |
Refinancing
|
86 | 98 | 99 | 81 |
Liquidity
|
29 | 21 | 29 | 18 |
|
34 | 59 | 67 | 39 |
Discover high‑ranked alternatives to Health Catalyst and broaden your portfolio horizons.
The Obermatt Advantage
Choose the Obermatt subscription that best fits your needs.